U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214870) titled 'A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat' on Oct. 06.
Brief Summary: The purpose of this clinical study is to find out if NNC4005-0001 is well-tolerated and safe for people who have increased body weight and increased liver fat. Participants will receive either NNC4005-0001, which is the treatment being tested, or a placebo, which is a treatment that contains no active medicine. The study will last for about for about 7 to 8 months.
Study Start Date: Oct. 07
Study Type: INTERVENTIONAL
Condition:
Fatty Liver Disease
Intervention: ...